series-a
Stage
1
Investors
About
Third Arc Bio develops multifunctional antibody therapeutics that engage multiple targets and immune cell types to treat complex diseases including solid tumors and immunology/inflammation conditions.
Explore Third Arc Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.